MedTrace Logo

Insulin on Post Burn Hypermetabolism

NCT00137254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2012-04-12

No results posted yet for this study

Summary

The purpose of this study is to examine the effects of insulin on helping burn patients recover faster from their burns.

Conditions

  • Burns

Interventions

DRUG

Insulin

IV insulin

DRUG

Stable Isotopes

IV administration of stable isotopes

DRUG

Indocyanine Green

IV administration of ICG

Sponsors & Collaborators

  • The University of Texas Medical Branch, Galveston

    collaborator OTHER

  • United States Army Institute of Surgical Research

    lead FED

Principal Investigators

  • Steven E Wolf, MD · US Army Institute of Surgical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-02-28
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00137254 on ClinicalTrials.gov